Patterns of acquired mutations in estrogen receptor-positive metastatic breast cancer (MBC) patients identified by comprehensive genomic profiling (CGP)

被引：0
|
作者：
McGregor, K. [1 ]
Ross, J. S. [2 ]
Danziger, N. A. [3 ]
Sokol, E. S. [4 ]
Venstrom, J. [5 ]
Chung, J. H. [5 ]
Lee, J. [5 ]
Alexander, B. [5 ]
Schrock, A. B. [5 ]
Tukachinsky, H. [1 ]
机构：
[1] Fdn Med Inc, Med Affairs, Boston, MA USA
[2] Fdn Med, Cambridge, MA USA
[3] Fdn Med Inc, Pathol, Cambridge, MA USA
[4] Fdn Med Inc, Canc Genom, Cambridge, MA USA
[5] Fdn Med, Clin Dev, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
305P
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [31] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [32] BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy
    Gornstein, Erica L.
    Sandefur, Sara
    Chung, Jon H.
    Gay, Laurie M.
    Holmes, Oliver
    Erlich, Rachel L.
    Soman, Salil
    Martin, L. Katherine
    Rose, Andrea V.
    Stephens, Philip J.
    Ross, Jeffrey S.
    Miller, Vincent A.
    Ali, Siraj M.
    Blau, Sibel
    CLINICAL BREAST CANCER, 2018, 18 (02) : 184 - 188
  • [33] Detection and functional analysis of estrogen receptor mutations (ESR1-mut) in patients with metastatic breast cancer (MBC).
    Puhalla, Shannon
    Wang, Peilu
    Bahreini, Amir
    Gyanchandani, Rekha
    Ambros, Tadeu Frantz
    Hartmaier, Ryan James
    Kurland, Brenda F.
    Lucas, Peter C.
    Bittar, Humberto E. Trejo
    Hamilton, Ronald L.
    Mathew, Aju
    Leone, Jose Pablo
    Davidson, Nancy E.
    Weiss, Kurt R.
    Watters, Rebecca J.
    Nikiforova, Marina
    Stern, Andrew M.
    Brufsky, Adam
    Lee, Adrian V.
    Oesterreich, Steffi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer
    Aggelis, Vassilis
    Johnston, Stephen R. D.
    DRUGS, 2019, 79 (17) : 1849 - 1866
  • [35] Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer
    Kaklamani, Virginia G.
    Gradishar, William J.
    ONCOLOGIST, 2017, 22 (05): : 507 - 517
  • [36] Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer
    Vassilis Aggelis
    Stephen R. D. Johnston
    Drugs, 2019, 79 : 1849 - 1866
  • [37] Overcoming tamoxifen resistance and inhibiting metastatic recurrence in estrogen receptor-positive breast cancer
    Ersan, Pelin Gulizar
    Saatci, Ozge
    Tarman, Oguzhan
    Mishra, Rasmi
    Belder, Nevin
    Tokat, Unal Metin
    Riazalhosseini, Yasser
    Sahin, Ozgur
    CANCER RESEARCH, 2019, 79 (13)
  • [38] New Strategies in Estrogen Receptor-Positive Breast Cancer
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 1979 - 1987
  • [39] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
  • [40] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
    Gucalp, Ayca
    Tolaney, Sara
    Isakoff, Steven J.
    Ingle, James N.
    Liu, Minetta C.
    Carey, Lisa A.
    Blackwell, Kimberly
    Rugo, Hope
    Nabell, Lisle
    Forero, Andres
    Stearns, Vered
    Doane, Ashley S.
    Danso, Michael
    Moynahan, Mary Ellen
    Momen, Lamia F.
    Gonzalez, Joseph M.
    Akhtar, Arooj
    Giri, Dilip D.
    Patil, Sujata
    Feigin, Kimberly N.
    Hudis, Clifford A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
12345